GHTC
@GHTCoalition
Followers
7K
Following
3K
Media
3K
Statuses
14K
Our mission is to advance innovation to save lives. GHTC is the leading advocacy org working to accelerate R&D for #globalhealth technologies. #innovate4health
Washington, DC
Joined February 2010
There are unique challenges and multiple steps in developing tools to improve the health of people living in low-resource settings worldwide. 🔬 🧬 ➡️ 💉 💊 Learn more about that R&D journey. #GlobalHealth
0
0
0
Impact Global Health estimates proposed US budget cuts could lower global health-related vaccine R&D by 41% & basic research by 42%, triggering global falls of 21% & 31%—that means fewer US-led breakthroughs, including vaccines, a key tool in our arsenal. https://t.co/eg2VAsAKWy
0
0
0
Only 3 in 10 Veterans know about 0% down home loans. Join our mission to help veterans find their way home.
7
6
62
Last week, @IAVI published new findings from the first-in-human Phase 1 clinical trial of its Lassa virus vaccine candidate, which show that one dose of the vaccine triggers robust and long-lasting immunity and is safe. @CEPIvaccines
https://t.co/v1aEWYncDG
0
0
0
Impact Global Health's new report finds that NIH grant cuts will reduce 2025 funding for HIV R&D by $18m, COVID by $15m, & malaria by $14M, while mpox, flaviviruses (Zika), uterine fibroids, and maternal iron deficiency face the biggest proportional hits. https://t.co/eg2VAsAKWy
0
0
0
Vector control remains at the heart of malaria progress. New @MalariaAtlas data show 1.22 billion cases and 3.5 million deaths have been prevented across Africa since 2000. A reminder of what sustained innovation can achieve. ✨ https://t.co/Vc4ljQ974q
#VectorControl #malaria
0
4
8
Only 6 days to go until our Union side event Innovate, Integrate, Impact: New Tools to END TB! We’re glad to welcome Dr Max Rath, Chief Medical Officer at AI Diagnostics, to Session 2: New Tech (14:30–15:15 CET). He will present on AI-powered digital stethoscope screening for
0
2
1
#RSV is a major cause of pneumonia in infants. But maternal RSV vaccines, now prequalified by @WHO, can offer a path forward to protect the most at-risk children. #RSVAwareness #WorldPneumoniaDay More here:
path.org
With new global recommendations in place, countries are poised to take next steps toward introducing maternal RSV vaccines and safeguarding infants from a major health threat.
0
3
5
This week, PATH is excited to attend the @ASTMH Annual Meeting in Toronto. We'll present new insights into #malaria & other tropical diseases and share innovative, data-driven strategies addressing #GlobalHealth challenges. Learn more: https://t.co/Jluqh6XAXz
#TropMed25
0
4
8
Congratulations, @CEPIvaccines! 🎉🏆
CEPI is truly honoured to receive @ResearchAmerica's 2026 Advocacy Award for Outstanding Achievement in Public Health. The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ��️ https://t.co/ua2fSimpXq
0
1
0
CEPI is truly honoured to receive @ResearchAmerica's 2026 Advocacy Award for Outstanding Achievement in Public Health. The award recognises a public–private partnership that has made a critical and timely contribution to public health progress ⬇️ https://t.co/ua2fSimpXq
researchamerica.org
Research!America urges the president and congressional leaders to come back to the table immediately to end the shutdown.
1
1
4
Make sure to join experts at the Antimicrobial Resistance Symposium 2025 hosted by @ChariteBerlin, focused on tackling Carbapenem-Resistant Enterobacterales (#CRE) 📍Berlin & online 🗓️ 21 Nov 2025 More details here: https://t.co/Ne0oVAiQal
0
2
2
New @MalariaAtlas research shows the impact of vector control in Africa. 🌍 Over one billion malaria cases prevented 🦟 ITNs most effective 📉 1.22 billion cases and 3.5 million deaths prevented 🔗 Read more: https://t.co/Vc4ljQ974q
#TropMed25 #EndMalaria #VectorControl
0
8
13
The world remains dangerously underprepared for future pandemics. A new report from the G20 HLIP – co-chaired by CEPI Board Chair, Jane Halton – warns urgent action is needed to close financing gaps and strengthen defences against biological threats. ⬇️ https://t.co/sBPSXDgmKN
nam.edu
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
1
1
2
The world remains dangerously underprepared for future pandemics. A new G20 High Level Independent Panel report, Closing the Deal, outlines key steps to strengthen global financing for pandemic prevention, preparedness, and response. Read the report: https://t.co/YZxrdHA2IG
1
4
5
On R&D, the report recommends that 💵Development finance institutions partner to accelerate geographically diversified access to medical countermeasures 💊Global and regional organizations coordinate to finance the development and scale-up of tests, treatments, and PPE
0
0
0
Global health financing is shrinking as pandemic risks rise. A G20 panel, which GHTC advised, is calling for urgent action from governments to protect against catastrophic losses. https://t.co/9zOcUvRg85
#PandemicPreparedness #GlobalHealthSecurity
nam.edu
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
1
0
0
In a Phase 1 trial, an experimental vaccine against multiple H5N1 avian flu strains generated a broad immune response, demonstrating the potential of such a vaccine to play a big role in preparing for outbreaks of emerging viruses with evolving strains. https://t.co/v1aEWYnKte
ghtcoalition.org
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
0
0
0
WHO's TB Vaccine Accelerator Council recently published a new report calling for action to ensure equitable access to future #tuberculosis vaccines currently in the pipeline. https://t.co/v1aEWYncDG
0
0
0
Impact Global Health's new report warns that USAID’s dissolution slashed key funding, stalling HIV prevention breakthroughs and vaccine R&D for emerging diseases—just as we were reaching a turning point in HIV and global outbreaks grow more likely. https://t.co/eg2VAsAKWy
0
0
0
What's new in #GlobalHealth R&D? 📣Call for action for future #TB vaccines 👃Intranasal H5 flu vaccine 💉Lassa vaccine trial https://t.co/v1aEWYnKte
ghtcoalition.org
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
0
0
0